Vimarsana
Biggest News Aggregation in the World

Page 15 - Mark Horowitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Horowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Horowitz Today - Breaking & Trending Today

Doctors have stopped believing that 'chemical imbalance' causes depression. They didn't tell us - Vimarsana News

Doctors have stopped believing that 'chemical imbalance' causes depression. They didn't tell us

Many think too little serotonin causes depression and antidepressants can fix that. But psychiatrists stopped believing that theory long ago

With 'Chemical Imbalance' Theory in Doubt, What's Next for Depression Care? - Vimarsana News

With 'Chemical Imbalance' Theory in Doubt, What's Next for Depression Care?

TUESDAY, Sept. 6, 2022 (HealthDay Now) -- For Mary Christ, the idea that depression is a chemical imbalance in the brain has always felt true to her personal experience.

Major Depression: The "Chemical Imbalance" Pillar Is Crumbling—Is the Genetics Pillar Next? - Vimarsana News

Major Depression: The "Chemical Imbalance" Pillar Is Crumbling—Is the Genetics Pillar Next?

A more detailed critical evaluation of MD molecular genetic studies, which have failed to discover genes shown to cause MD.

Are Antidepressants Better Than Placebo for Some? Not So Fast, Researchers Caution - Vimarsana News

Are Antidepressants Better Than Placebo for Some? Not So Fast, Researchers Caution

Recent study finding antidepressants beat placebo for 15% doesn’t account for study unblinding and includes only extremely short-term data.

Is a new fast-acting pill for depression the Holy Grail that patients have been waiting for? - Vimarsana News

Is a new fast-acting pill for depression the Holy Grail that patients have been waiting for?

The FDA approval for the twice-daily pill comes just three months after the publication of positive results of a clinical trial, where it was compared against a placebo.